Akari Therapeutics, Plc Basic Shares Outstanding (Weighted Average)
Akari Therapeutics, Plc (AKTX) reported Basic Shares Outstanding (Weighted Average) of 143.32 billion shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Akari Therapeutics, Plc weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 143.32B shares, a 127.69% increase year-over-year.
- Akari Therapeutics, Plc weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 118.76B shares, a 117.55% increase year-over-year.
- Akari Therapeutics, Plc weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 86.41B shares, a 122.60% increase year-over-year.
- Akari Therapeutics, Plc weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 65.33B shares, a 167.88% increase year-over-year.
- Akari Therapeutics, Plc weighted average number of shares outstanding, basic for fiscal 2025 was 67.33B shares, a 181.85% increase from fiscal 2024.
- Akari Therapeutics, Plc weighted average number of shares outstanding, basic for fiscal 2024 was 23.89B shares, a 144.03% increase from fiscal 2023.
- Akari Therapeutics, Plc weighted average number of shares outstanding, basic for fiscal 2023 was 9.79B shares.
- Akari Therapeutics, Plc weighted average number of shares outstanding, basic for fiscal 2013 was 21.08M shares, a 69.16% increase from fiscal 2012.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 143.32B shares 10-Q · filed 2026-08-13 | 131.04B shares 10-Q · filed 2026-08-13 | 116.16B shares derived: average of 3 quarters · filed 2026-08-13 | 103.45B shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | 118.76B shares 10-Q · filed 2026-05-19 | 102.58B shares derived: average of 2 quarters · filed 2026-05-19 | 90.16B shares derived: average of 3 quarters · filed 2026-05-19 | 83.36B shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | 86.41B shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 75.87B shares derived: average of 2 quarters · filed 2026-03-30 | 71.56B shares derived: average of 3 quarters · filed 2026-08-13 | 67.33B shares 10-K · filed 2026-03-30 | |||
| 2025-09-30 | 65.33B shares 10-Q · filed 2025-11-13 | 64.14B shares derived: average of 2 quarters · filed 2026-08-13 | 60.97B shares 10-Q · filed 2025-11-13 | 55.42B shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | 62.94B shares 10-Q · filed 2026-08-13 | 58.77B shares 10-Q · filed 2026-08-13 | 52.12B shares derived: average of 3 quarters · filed 2026-08-13 | 45.18B shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | 54.59B shares 10-Q · filed 2026-05-19 | 46.70B shares derived: average of 2 quarters · filed 2026-05-19 | 39.26B shares derived: average of 3 quarters · filed 2026-05-19 | 34.16B shares derived: average of 4 quarters · filed 2026-05-19 | |||
| 2024-12-31 | 38.82B shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 31.60B shares derived: average of 2 quarters · filed 2026-03-30 | 27.35B shares derived: average of 3 quarters · filed 2026-03-30 | 23.89B shares 10-K · filed 2026-03-30 | |||
| 2024-09-30 | 24.39B shares 10-Q · filed 2025-11-13 | 21.61B shares derived: average of 2 quarters · filed 2025-11-13 | 18.91B shares 10-Q · filed 2025-11-13 | 16.37B shares derived: average of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | 18.84B shares 10-Q · filed 2025-08-13 | 16.14B shares 10-Q · filed 2025-08-13 | 13.70B shares derived: average of 3 quarters · filed 2025-08-13 | 12.80B shares derived: average of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | 13.45B shares 10-Q · filed 2025-05-14 | 11.13B shares derived: average of 2 quarters · filed 2025-05-14 | 10.79B shares derived: average of 3 quarters · filed 2025-05-14 | 8.10B shares derived: average of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | 8.80B shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 9.46B shares derived: average of 2 quarters · filed 2025-04-15 | 6.31B shares derived: average of 3 quarters · filed 2025-04-15 | 9.79B shares 10-K · filed 2025-04-15 | |||
| 2023-09-30 | 10.12B shares 10-Q · filed 2024-11-19 | 5.07B shares derived: average of 2 quarters · filed 2024-11-19 | 10.12B shares 10-Q · filed 2024-11-19 | ||||
| 2023-06-30 | 20.25M shares 8-K · filed 2024-09-06 | 10.12B shares 10-Q · filed 2024-08-19 | 20.05M shares 8-K · filed 2024-09-06 | 8.79B shares 6-K · filed 2023-09-29 | |||
| 2023-03-31 | 7.47B shares 10-Q · filed 2024-05-15 | ||||||
| 2022-12-31 | 17.71M shares 8-K · filed 2024-09-06 | 6.24B shares 20-F · filed 2023-05-01 | |||||
| 2022-06-30 | 5.93B shares 6-K · filed 2022-09-27 | 5.65B shares 6-K · filed 2023-09-29 | |||||
| 2021-12-31 | 4.29B shares 20-F · filed 2023-05-01 | ||||||
| 2021-06-30 | 3.85B shares 6-K · filed 2022-09-27 | 3.87B shares 6-K · filed 2022-09-27 | |||||
| 2020-12-31 | 3.16B shares 20-F · filed 2023-05-01 | ||||||
| 2019-12-31 | 1.83B shares 20-F · filed 2022-05-16 | ||||||
| 2019-06-30 | 1.61B shares 6-K · filed 2019-08-29 | 1.59B shares 6-K · filed 2019-08-29 | |||||
| 2018-12-31 | 1.54B shares 20-F · filed 2021-04-21 | ||||||
| 2018-06-30 | 1.53B shares 6-K · filed 2019-08-29 | 1.53B shares 6-K · filed 2019-08-29 | |||||
| 2017-12-31 | 1.25B shares 20-F · filed 2020-03-31 | ||||||
| 2017-06-30 | 1.18B shares 6-K · filed 2018-09-27 | 1.18B shares 6-K · filed 2018-09-27 | |||||
| 2016-12-31 | 1.18B shares 20-F · filed 2019-04-23 | ||||||
| 2016-06-30 | 1.18B shares 6-K · filed 2017-08-10 | 1.18B shares 6-K · filed 2017-08-10 | 1.18B shares derived: average of 3 quarters · filed 2018-07-18 | 1.08B shares derived: average of 4 quarters · filed 2018-07-18 | |||
| 2016-03-31 | 1.18B shares 10-Q · filed 2016-05-12 | 1.18B shares derived: average of 2 quarters · filed 2018-07-18 | 1.05B shares derived: average of 3 quarters · filed 2018-07-18 | 965.76M shares derived: average of 4 quarters · filed 2018-07-18 | |||
| 2015-12-31 | 1.18B shares derived: 20-F 12 month − 10-Q 9 month · filed 2018-07-18 | 981.51M shares derived: average of 2 quarters · filed 2018-07-18 | 895.12M shares derived: average of 3 quarters · filed 2018-07-18 | 852.09M shares 20-F · filed 2018-07-18 | |||
| 2015-09-30 | 781.74M shares 10-Q · filed 2015-11-23 | 752.04M shares derived: average of 2 quarters · filed 2017-04-14 | 742.36M shares 10-Q · filed 2015-11-23 | 587.40M shares derived: average of 4 quarters · filed 2017-04-14 | |||
| 2015-06-30 | 722.35M shares derived: 6-K 6 month − 10-Q 3 month · filed 2017-04-14 | 722.35M shares 6-K · filed 2017-04-14 | 522.62M shares derived: average of 3 quarters · filed 2017-04-14 | 410.30M shares derived: average of 4 quarters · filed 2017-04-14 | |||
| 2015-03-31 | 722.35M shares 10-Q · filed 2016-05-12 | 422.75M shares derived: average of 2 quarters · filed 2017-03-31 | 306.29M shares derived: average of 3 quarters · filed 2017-03-31 | ||||
| 2014-12-31 | 123.16M shares derived: 20-F 12 month − 10-Q 9 month · filed 2017-03-31 | 98.26M shares derived: average of 2 quarters · filed 2017-03-31 | 85.52M shares 20-F · filed 2017-03-31 | 54.12M shares 10-K · filed 2015-02-11 | |||
| 2014-09-30 | 73.37M shares 10-Q · filed 2015-11-23 | 72.97M shares 10-Q · filed 2015-11-23 | |||||
| 2013-12-31 | 21.08M shares 10-K · filed 2015-02-11 | ||||||
| 2012-12-31 | 12.46M shares 10-K · filed 2015-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |